Editor's Pick Universal DX Eyeing Approval for Colorectal Cancer Early Detection Test After Positive Data Premium The firm plans to present data from a large validation study of the Signal-C early detection test later this year as it contemplates approval. SolveBio Acquisition Fuels QuartzBio's Ambitions in Biomarker Discovery Premium In purchasing startup SolveBio, Precision for Medicine's QuartzBio saw an opportunity to augment its genomic and clinical data analytics during a growth phase. Ampel BioSolutions, Duke Researchers Establish Fibromyalgia Gene Signature Premium Ampel will use the signature to develop FibroGene, a fibromyalgia blood test that the company expects to launch next year. Foundation Medicine, Natera Launch Early Access for Clinical Personalized ctDNA Monitoring Test Premium The personalized and targeted tumor assay, also available for research use in clinical trials, provides a surrogate measure of tumor burden from blood samples. NY Genome Center Team Harnesses Ultima Genomics Platform for High-Sensitivity ctDNA Sequencing Premium Taking advantage of the new platform's low sequencing cost, the researchers sequenced cell-free circulating DNA (ccfDNA) in plasma at high depth for sensitive cancer monitoring. Jan 24, 2023 New Study Results Boost Evidence for Natera's MRD Assays to Guide Adjuvant Therapy Decisions Premium Jan 19, 2023 Colorectal Cancer Detection Data from CellMax Life Bodes Well for Planned FDA Bid Premium Jan 19, 2023 Snyder Lab Combines Microsampling, Multiomics for Health Tracking, Biomarker Discovery Premium Jan 13, 2023 Estonian Team Building Personalized Medicine Center of Excellence With €30M in National, EU Funding Premium Jan 12, 2023 Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease Premium Jan 12, 2023 Cedars Sinai Team Develops Method for Quantitative Label-Free Proteomics Without LC Separation Premium Jan 5, 2023 Sequencing Instrument Launches in 2022 Portend Heated Competition Premium Jan 5, 2023 Macroeconomic Worries Lead to More Subdued Omics, MDx M&A Activity in 2022 Premium Jan 4, 2023 Absent Resolution on FDA's LDT Oversight in 2022, Some Payors Began Advancing Their Own Requirements Premium Dec 21, 2022 Genomics Firms Tackle Carbon Emissions, Face Obstacles to Net-Zero Goals From Suppliers, Shipping Premium Dec 19, 2022 MGI Tech Heads Full Steam Into US Market Despite Data Security Accusations, Image Problems Premium Dec 9, 2022 Texas Whole-Exome Sequencing Project Aims to Help Address Disparities in Genomic Medicine Premium Dec 8, 2022 Analysis of CMS Data Raises Alarm on Potential Genetic Testing Fraud Premium Dec 7, 2022 With $6M in Seed Funding, Swedish Startup Pixelgen Developing Tech to Map Cell Surface Proteins Premium Dec 2, 2022 UChicago Testing Pharmacogenomics for Surgical Patients in Clinical Trial Premium Nov 30, 2022 Amazon Omics Debuts With Lofty Expectations in Crowded Marketplace Premium Nov 30, 2022 Bladder Cancer Genomic Landscape Study Aims to Engender New Biomarker-Guided Therapies Premium Nov 29, 2022 Human Protein Atlas Using Olink Tech to Move Into Plasma Proteomic Profiling of Disease States Premium Nov 28, 2022 Juno Diagnostics Lowers Barriers to Noninvasive Prenatal Testing With At-Home Sample Collection Premium Nov 22, 2022 Foundation Medicine Probing Tumor Fraction Influence on Negative Liquid Biopsies Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.